Trial record 2 of 31 for:    Open Studies | "Retinal Detachment"

Comparison High-Density Silicone Oils in Retinal Detachment

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2006 by Asociación para Evitar la Ceguera en México.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Asociación para Evitar la Ceguera en México
ClinicalTrials.gov Identifier:
NCT00403702
First received: November 2, 2006
Last updated: June 28, 2009
Last verified: November 2006
  Purpose

The purpose of the study is to compare the safety, intraocular adverse effects and the anatomic and functional outcome with two endotamponade silicone oil after a 3-month in complex inferior retinal re-detachments.


Condition Intervention Phase
Retinal Detachment
Drug: Oxane HD [oil-RMN3-mixture]
Drug: Densiron [(F6H8)
Phase 2
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Official Title: Comparison of Two High-Density Silicone Oils in Complicated Rhegmatogenous Retinal Detachment

Resource links provided by NLM:


Further study details as provided by Asociación para Evitar la Ceguera en México:

Primary Outcome Measures:
  • visual acuity
  • anatomical results

Secondary Outcome Measures:
  • complication: hypotony,
  • vitreous hemorrhage,
  • inflammatory reaction,
  • cataract,
  • chronic hypotony,
  • IOP elevated intraocular pressure,
  • pseudohypopyon,
  • fibrin,
  • emulsification droplets in the anterior chamber

Estimated Enrollment: 10
Study Start Date: August 2006
Estimated Study Completion Date: August 2007
Detailed Description:

Five to 10% of retinal detachments progressed to proliferative vitreoretinopathy (PVR), the common more cause of surgical failure of retina detachment.

Despite the use of internal tamponades, the treatment of retinal detachments due to a progressed proliferative vitreoretinopathy (PVR) is still a problem. At present, conventional silicone oil, having a lower specific gravity than water, is an excellent tool in advanced PVR retinal detachment especially of the upper circumference.

In the past, to diminish the re-detachments diverse heavier-than-water density endotamponades were investigated by to use in in cases of inferior PVR. However,heavier-than-water density endotamponades have demonstrated adverse short term effects. (Example: silicon dispersion: hypotension and inflammation)

Recently, two new long-term heavier-than-water internal tamponades were introduced: Oxane HD [oil-RMN3-mixture] and Densiron [mixture of 30.5 vol% perfluorohexyloctane (F6H8) with 69.5 vol% polydimethylsiloxane (silicone oil)], showing satisfying anatomical results and good intraocular tolerance.

In the present study, we will compare the anatomical outcome, functional results and intraocular adverse effects of two types of heavier tamponades.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients complicated persistent retinal detachment due secondary to proliferative vitreoretinopathy

Exclusion Criteria:

  • Diabetes
  • Uveitis
  • Glaucoma
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00403702

Contacts
Contact: Jose Luis Diaz-Rubio, MD +52 (55) 10841400 ext 1172 retinamex@yahoo.com

Locations
Mexico
Asociacion Para Evitar la Ceguera en Mexico Recruiting
Mexico, D.F, Mexico, 04330
Contact: yoko burgoa    +52 (55) 1084 1400 ext 1171    retinamex@yahoo.com   
Contact: Mariana Martinez    +52 (55) 1084 1400 ext 1171    retinamex@yahoo.com   
Principal Investigator: Jose Luis Diaz-Rubio, MD         
Sub-Investigator: Maximiliano Gordon         
Sub-Investigator: Veronica Kon-Jara         
Sub-Investigator: Mitzy Torres         
Sub-Investigator: Orlando Ustariz         
Sub-Investigator: Gerardo Garcia-Aguirre         
Sponsors and Collaborators
Asociación para Evitar la Ceguera en México
Investigators
Study Director: Hugo Quiroz-Mercado, MD Asociación para Evitar la Ceguera en México
  More Information

Publications:

ClinicalTrials.gov Identifier: NCT00403702     History of Changes
Other Study ID Numbers: APEC-0021
Study First Received: November 2, 2006
Last Updated: June 28, 2009
Health Authority: Mexico: Ethics Committee
Mexico: Ministry of Health

Keywords provided by Asociación para Evitar la Ceguera en México:
Retinal detachment
proliferative vitreoretinopathy
heavier-than-water internal tamponades

Additional relevant MeSH terms:
Retinal Detachment
Dissociative Disorders
Retinal Diseases
Eye Diseases
Mental Disorders

ClinicalTrials.gov processed this record on August 28, 2014